Literature DB >> 31534307

Entropy Learning for Dynamic Treatment Regimes.

Binyan Jiang1, Rui Song2, Jialiang Li3, Donglin Zeng4.   

Abstract

Estimating optimal individualized treatment rules (ITRs) in single or multi-stage clinical trials is one key solution to personalized medicine and has received more and more attention in statistical community. Recent development suggests that using machine learning approaches can significantly improve the estimation over model-based methods. However, proper inference for the estimated ITRs has not been well established in machine learning based approaches. In this paper, we propose a entropy learning approach to estimate the optimal individualized treatment rules (ITRs). We obtain the asymptotic distributions for the estimated rules so further provide valid inference. The proposed approach is demonstrated to perform well in finite sample through extensive simulation studies. Finally, we analyze data from a multi-stage clinical trial for depression patients. Our results offer novel findings that are otherwise not revealed with existing approaches.

Entities:  

Keywords:  Dynamic treatment regime; entropy learning; personalized medicine

Year:  2019        PMID: 31534307      PMCID: PMC6750237          DOI: 10.5705/ss.202018.0076

Source DB:  PubMed          Journal:  Stat Sin        ISSN: 1017-0405            Impact factor:   1.261


  19 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

3.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

4.  A robust method for estimating optimal treatment regimes.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrics       Date:  2012-05-02       Impact factor: 2.571

5.  Penalized Q-Learning for Dynamic Treatment Regimens.

Authors:  R Song; W Wang; D Zeng; M R Kosorok
Journal:  Stat Sin       Date:  2015-07       Impact factor: 1.261

6.  New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Ying-Qi Zhao; Donglin Zeng; Eric B Laber; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

7.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Jonathan W Stewart; Andrew A Nierenberg; Michael E Thase; Louise Ritz; Melanie M Biggs; Diane Warden; James F Luther; Kathy Shores-Wilson; George Niederehe; Maurizio Fava
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

8.  Super-Learning of an Optimal Dynamic Treatment Rule.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

9.  Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

10.  A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Authors:  Maurizio Fava; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan E Alpert; Patrick J McGrath; Michael E Thase; Diane Warden; Melanie Biggs; James F Luther; George Niederehe; Louise Ritz; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

View more
  1 in total

1.  Multithreshold change plane model: Estimation theory and applications in subgroup identification.

Authors:  Jialiang Li; Yaguang Li; Baisuo Jin; Michael R Kosorok
Journal:  Stat Med       Date:  2021-04-11       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.